log  
logo
A Journal of Postdoctoral Research.
 
     Login   |   Register   
    ISSN : 2328-9791
left right
 
 
INVITED EDITORIAL : Recent developments in antimicrobial peptide and bacterial biofilm re
     
 
César de la Fuente-Núñez
University of British Columbia
Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, UBC, 2329 West Mall, Vancouver, British Columbia
cesar@hancocklab.com

Each year, 25,000 people die in Europe as a result of antibiotic-resistant infections, costing the European Union >1.5 billion euros. A similar scenario takes place in the United States, where >2 million people are infected with drug-resistant bacteria leading to 23,000 deaths annually. In addition to the increase in bacterial resistance to available antibiotics, no antimicrobials designed to combat these recalcitrant infections have been approved for use in humans.

However, in recent years increasing effort has been devoted to identifying strategies against persistent infections. One such approach is the use of antimicrobial peptides (AMPs) as templates to generate synthetic peptide variants with improved activity. AMPs are evolutionarily conserved.

 
btm
 
top
 
 
 
 
 
btm

 
footer
 
 
home phone mail info@postdocjournal.com
 
twitter facebook social icon Social link You Tube sky
Click Here